On 6/5/24, MacroGenics Inc (NASDAQ: MGNX) stock enjoyed a major increase of 12.6%, closing at $4.91. However, trading volume in this advance was unusually low at 58% of normal. The stock has risen 13.1% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, MGNX is expected to continue to be a major Value Builder.
MacroGenics has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. MacroGenics has a very low Appreciation Score of 14 but a very high Power Rating of 89, and the Neutral Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment